Navigation Links
ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
Date:10/7/2008

EMERYVILLE, Calif., Oct. 7 /PRNewswire/ -- ProGenTech Limited, a life sciences & diagnostics company based in Shanghai, China and Emeryville, CA has signed a licensing agreement with Human Genetic Signatures, a Sydney, Australia based life science company to gain access to key hospital-acquired infection targets, payment terms were not disclosed.

Under the terms of the agreement, Human Genetic Signatures will develop assays for MRSA, MSSA, VRE and C. difficile which will then be further integrated into the ProGenTech Entura platforms. It is anticipated that manual assays for these initial targets will be taken to the FDA during 2009 followed by fully integrated and automated versions of the assays in 2010. Launching these assays will mark ProGenTech's initial foray into the molecular diagnostics market.

Dr. Trevor Hawkins, the Chairman & CEO of ProGenTech said, "We are very excited to be working with Human Genetic Signatures to develop and commercialize these assays. The advantages of our 'Press play and walk away(TM)' Entura systems together with the Human Genetic Signatures' 3base(TM) simplification technology will provide a valuable solution to the underserved hospital-acquired infections market."

"Our 3base(TM) assay technology is a natural fit with the current and future Entura systems," said Angus Hastie, CEO of Human Genetic Signatures. "Market trends are indicating that fast and easy to use modular platforms are a powerful path forward for molecular diagnostics. ProGenTech's platform vision in concert with a menu empowered by 3base(TM) assays will deliver new clinical benefits and the complete diagnostics package to this burgeoning market."

The key advantage of ProGenTech's Entura platforms is that they greatly reduce the total hands on time historically associated with sample preparation. The Entura uses a unique cassette-based approach in which all reagents for RNA, DNA or protein applications are pre-loaded in the casset
'/>"/>

SOURCE ProGenTech Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ProGenTech Completes $21 Million Series C Financing
2. ProGenTech Limited Appoints Executive Management Team
3. U.S. Health Initiative Targets Aging Hispanics
4. Global Health Project targets reducing AIDS among Indias adolescents
5. GP targets on heart disease should be simpler and based more on treatment and prevention
6. International Law Enforcement Operation Targets Underground Manufacture of Anabolic Steroids
7. OralLongevity (TM) Program Targets Oral Health of Older Americans
8. AWWA Water 101 Seminar Targets Sales, Marketing and PR Pros
9. Combination targets: some drugs may work best when they work together
10. Targets on the horizon: Emerging therapies and novel targets
11. Anti-smoking strategy targets fourth-graders, parents in rural and urban Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have made a brain-related discovery that could revolutionize ... This discovery opens up the possibility that environmental ... specific brain activity that the researchers have identified ... Journal of Neuroscience has just published a ... associate professor of psychology and his doctoral student ...
(Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... Reporter , TUESDAY, April 3 (HealthDay News) -- Several Rhode ... of sharp wire bristles that made their way from barbecue ... which came from the metallic brushes used to clean grills, ... patients ate, a new report said. From there, the bristles ...
... used by cancer and transplant patients, and there are hints that it ... it also comes with a downside: rapamycin leads to diabetes in as ... Now, researchers reporting in the April Cell Metabolism , a Cell ... insulin signal off in muscle, to prevent muscle cells from taking blood ...
... TUESDAY, April 3 (HealthDay News) -- A vaccination may help ... small new study reports. The prognosis for many ... is the only effective treatment, although there has been hope ... The results of the new study, which included 27 children ...
... blood vessels earlier than previously thought, and these structural ... the development of high blood pressure. These findings in ... of Virginia School of Medicine in the US, are ... Research . With age, increasing weight and metabolic ...
... Women having children at older ages and the growing availability ... the birth of twins: In 2009, one in every 30 ... with one in every 53 in 1980. The findings, ... the 14th Congress of the International Society of Twin Studies ...
... is a disconnect between the number of cancer patients estimated to ... for orthopedic care each year, states an article in the ... 140 000 new cases of cancer diagnosed in Canada each year ... are referred to orthopedic services even though they could benefit in ...
Cached Medicine News:Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 2Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 3Health News:How a cancer drug leads to diabetes 2Health News:Study Suggests Vaccine May Help Kids With Brain Cancer 2Health News:Arteries under pressure early on 2Health News:Seeing double: 1 in 30 babies born in US is a twin 2
(Date:1/15/2014)... and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental ... order to treat dental impairments, for tooth restoration and ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Everist Genomics, a rapidly growing personalized medicine company ... today that it has successfully completed acquisition of ... developer of the AngioDefender™ diagnostic device for assessing ... biomarker of early-stage atherosclerosis and CVD; it is ...
... 31, 2011 Baxano, Inc., a Silicon Valley based ... for spinal decompression surgery, announces a rapid expansion of ... its products. This continued expansion in ... new and existing accounts throughout the U.S. while providing ...
Cached Medicine Technology:Everist Genomics Announces Acquisition of Angiologix, Inc. 2Everist Genomics Announces Acquisition of Angiologix, Inc. 3Everist Genomics Announces Acquisition of Angiologix, Inc. 4Everist Genomics Announces Acquisition of Angiologix, Inc. 5Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System 2
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Flat serrated handle with polished finish. Without lock....
... A simple, effective method for determining ... Provides reliable data which can be applied ... problems. The set consists of four trays ... reference caps that have incremental hue variation ...
... D15 test evaluation has a choice ... caps with automatic creation 'horse-shoe' diagrams, ... deficiency analysis, calculation of color confusion ... eye selection (OD, OS, OU) and ...
Medicine Products: